Steady-state kinetic mechanism, stereospecificity, substrate and inhibitor specificity of Enterobacter cloacae nitroreductase

被引:107
作者
Koder, RL
Miller, AF
机构
[1] Johns Hopkins Univ, Dept Biophys, Baltimore, MD 21218 USA
[2] Johns Hopkins Univ, Dept Chem, Baltimore, MD 21218 USA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY | 1998年 / 1387卷 / 1-2期
基金
美国国家科学基金会;
关键词
nitroreductase; flavoprotein; ping-pong; stereospecificity; bioremediation;
D O I
10.1016/S0167-4838(98)00151-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Enterobacter cloacae nitroreductase (NR) is a flavoprotein which catalyzes the pyridine nucleotide-dependent reduction of nitroaromatics. Initial velocity and inhibition studies have been performed which establish unambiguously a ping-pong kinetic mechanism, NADH oxidation proceeds stereospecifically with the transfer of the pro-R hydrogen to the enzyme and the amide moiety of the nicotinamide appears to be the principal mediator of the interaction between NR and NADH. 2,4-Dinitrotoluene is the most efficient oxidizing substrate examined, with a k(cat)/K-M an order of magnitude higher than those of p-nitrobenzoate, FMN, FAD or riboflavin. Dicoumarol is a potent inhibitor competitive vs. NADH with a K-i of 62 nM. Several compounds containing a carboxyl group are also competitive inhibitors vs. NADH. Yonetani-Theorell analysis of dicoumarol and acetate inhibition indicates that their binding is mutually exclusive, which suggests that the two inhibitors bind to the same site on the enzyme. NAD(+) does not exhibit product inhibition and in the absence of an electron acceptor, no isotope exchange between NADH and P-32-NAD(+) could be detected. NR catalyzes the 4-electron reduction of nitrobenzene to hydroxylaminobenzene with no optically detectable net formation of the putative two-electron intermediate nitrosobenzene. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:395 / 405
页数:11
相关论文
共 67 条
  • [1] THE BIOACTIVATION OF 5-(AZIRIDIN-1-YL)-2,4-DINITROBENZAMIDE (CB1954) .1. PURIFICATION AND PROPERTIES OF A NITROREDUCTASE ENZYME FROM ESCHERICHIA-COLI - A POTENTIAL ENZYME FOR ANTIBODY-DIRECTED ENZYME PRODRUG THERAPY (ADEPT)
    ANLEZARK, GM
    MELTON, RG
    SHERWOOD, RF
    COLES, B
    FRIEDLOS, F
    KNOX, RJ
    [J]. BIOCHEMICAL PHARMACOLOGY, 1992, 44 (12) : 2289 - 2295
  • [2] BIOACTIVATION OF DINITROBENZAMIDE MUSTARDS BY AN ESCHERICHIA-COLI-B NITROREDUCTASE
    ANLEZARK, GM
    MELTON, RG
    SHERWOOD, RF
    WILSON, WR
    DENNY, WA
    PALMER, BD
    KNOX, RJ
    FRIEDLOS, F
    WILLIAMS, A
    [J]. BIOCHEMICAL PHARMACOLOGY, 1995, 50 (05) : 609 - 618
  • [3] Bailey SM, 1996, GENE THER, V3, P1143
  • [4] METABOLIC-ACTIVATION OF THE GENOTOXIC ENVIRONMENTAL CONTAMINANTS 2-NITROFLUORANTHENE AND 3-NITROFLUORANTHENE IN VARIANTS OF SALMONELLA-TYPHIMURIUM TA98
    BALL, LM
    STOCKING, LM
    KOHAN, MJ
    WARREN, SH
    LEWTAS, J
    [J]. MUTAGENESIS, 1995, 10 (06) : 497 - 504
  • [5] BELAND FA, 1989, DNA BINDING 1 NITROP, P1
  • [6] Expression of the bacterial nitroreductase enzyme in mammalian cells renders them selectively sensitive to killing by the prodrug CB1954
    Bridgewater, JA
    Springer, CJ
    Knox, RJ
    Minton, NP
    Michael, NP
    Collins, MK
    [J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A (13-14) : 2362 - 2370
  • [7] The bystander effect of the nitroreductase CB 1954 enzyme prodrug system is due to a cell-permeable metabolite
    Bridgewater, JA
    Knox, RJ
    Pitts, JD
    Collins, MK
    Springer, CJ
    [J]. HUMAN GENE THERAPY, 1997, 8 (06) : 709 - 717
  • [8] BRYANT C, 1991, J BIOL CHEM, V266, P4119
  • [9] BRYANT C, 1991, J BIOL CHEM, V266, P4126
  • [10] BRYANT CP, 1990, THESIS UCSD SAN DIEG